SHUTTLE PHARMACEUTICALS HOLDINGS, INC. Fair Value Adjustment of Warrants
SHUTTLE PHARMACEUTICALS HOLDINGS, INC. (SHPH) reported Fair Value Adjustment of Warrants of $2.06 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-09-24.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2026-09-24
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. fair value adjustment of warrants for the quarter ending 2022-12-31 was $492.70K.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. fair value adjustment of warrants for the quarter ending 2022-09-30 was -$112.80K, a 522.70% decline year-over-year.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. fair value adjustment of warrants for the quarter ending 2021-12-31 was -$548.17K.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. fair value adjustment of warrants for the quarter ending 2021-09-30 was $26.68K.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. fair value adjustment of warrants for fiscal 2024 was -$395.08K.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. fair value adjustment of warrants for fiscal 2022 was $398.68K.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. fair value adjustment of warrants for fiscal 2021 was -$579.15K.
| Period end | Fair Value Adjustment of Warrants | Fair Value Adjustment of Warrants 1 month | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 12 month | Fair Value Adjustment of Warrants 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $2.06M 10-Q · filed 2026-09-24 | ||||||
| 2024-12-31 | -$395.08K 10-K · filed 2025-02-26 | ||||||
| 2022-12-31 | $492.70K derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-09-04 | $379.90K derived: sum of 2 quarters · filed 2024-09-04 | $398.68K 10-K/A · filed 2024-09-04 | -$94.03K 10-K · filed 2023-03-15 | |||
| 2022-09-30 | $30.00K 10-Q · filed 2022-11-14 | -$112.80K 10-Q · filed 2022-11-14 | -$94.03K 10-Q · filed 2022-11-14 | ||||
| 2022-08-01 | $146.62K 10-K/A · filed 2024-09-04 | ||||||
| 2021-12-31 | -$548.17K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | -$521.49K derived: sum of 2 quarters · filed 2023-03-15 | -$579.15K 10-K · filed 2023-03-15 | ||||
| 2021-12-28 | $16.67K 10-Q · filed 2022-11-14 | ||||||
| 2021-09-30 | $26.68K 10-Q · filed 2022-11-14 | -$30.97K 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |